ArticlePLOS global public health2025
Prevalence and correlates of sexual violence against adolescents: Quantitative evidence from rural and urban communities in South-West Nigeria.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Prevalence and factors associated with sexual abuse among in-school adolescents in Ogun State, Southwest, Nigeria.Scientific reports · 2026Article
- Suicidal Thoughts and Behaviors Among Chinese Adolescents in Relation to Negative Life Events, Internet Addiction, and Sexual Abuse: Cross-Sectional Study.Journal of medical Internet research · 2026Article
- Prevalence and correlates of risky sexual behaviour among in-school adolescents in Bulawayo, Zimbabwe: a cross-sectional study.BMJ public health · 2026Article
- Seroprevalence and Risk Factors for Hepatitis B, HIV, and Syphilis Among Survivors of Sexual Violence in the Eastern Cape Province, South Africa.Pathogens (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the recognized need to address the prevention of sexual violence against adolescents in Nigeria, significant research gaps persist in understanding the patterns, determinants, and impacts of such violence, particularly regarding regional variations and the specific developmental needs of adolescents across different stages. This study provides Nigerian regional prevalence estimates disaggregated by gender, rural/urban, and in/out-of-school populations, while also identifying socio-demographic and cultural determinants related to increased vulnerability. A cross-sectional survey was conducted in South-West Nigeria with a sample of 961 adolescents, targeting in- and out-of-school adolescents aged 13-17 years. Descriptive statistics and logistic regression analyses were performed.The prevalence of any form of SV since age 12 was 69.4%, with higher rates among out-of-school adolescents and boys. Non-contact abuse (63.2%), passive contact abuse (41.9%), and active contact abuse (28.7%) were the most common forms reported. Peers were the dominant perpetrators (77.1%), followed by other adults (27.9%). Being male (OR 2.033), older (OR 1.214 per year), involved in a romantic relationship (OR 2.731), and experiencing SV before age 12 (OR 4.622) were significant risk factors. Higher household wealth (OR 0.902 per asset) and emotional support from both parents (OR 0.413) were protective factors.This study highlights the high burden of SV against adolescents in Nigeria, with concerning patterns of male victimization and peer perpetration. The findings emphasize the need for comprehensive, evidence-based strategies addressing emotional support, social norms, power dynamics, and economic vulnerabilities to prevent and respond to this problem effectively.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.